Table 1.
Clinical characteristics of the HCs and KTRs.
| Parameters | HCs (n = 26) | KTRs | P value# | |||
|---|---|---|---|---|---|---|
| All KTRs (n = 115) | Stable KTRs (n = 65) | Infection KTRs (n = 50) | P value* | |||
| Male recipient, n (%) | 15 (57.7%) | 70 (60.9%) | 45 (69.2%) | 25 (50.0%) | 0.036 | 0.428 |
| Age, yrs ± SD | 31.31 ± 10.65 | 42.02 ± 12.16 | 44.55 ± 9.56 | 44.30 ± 13.05 | 0.112 | < 0.001 |
| Donor, n (%) | NA | 0.743 | NA | |||
| DCD | 83 (72.2%) | 49 (69.2%) | 34 (68.0%) | |||
| Relative | 32 (27.8%) | 16 (30.8%) | 16 (32.0%) | |||
| Infection site, n (%) | NA | NA | NA | NA | NA | |
| Pneumonia | 27 (54%) | |||||
| Urinary infection | 17 (34%) | |||||
| Other infection | 6 (12%) | |||||
| Calcineurin inhibitor, n (%) | NA | 0.412 | NA | |||
| Tacrolimus | 108 (93.9%) | 60 (92.3%) | 48 (96.0%) | |||
| Cyclosporine A | 7 (6.1%) | 5 (7.7%) | 2 (4.0%) | |||
| Time from transplant to 1st test, months ± SD | NA | 62.64± 52.90 | 69.86 ± 48.69 | 53.26 ± 57.06 | 0.295 | NA |
| WBC (109/L) | NA | 7.29 ± 3.27 | 6.78 ± 2.10 | 7.94 ± 4.28 | 0.076 | NA |
| Neu (109/L) | NA | 7.02 ± 10.83 | 6.48 ± 11.18 | 7.74 ± 10.43 | 0.537 | NA |
| Lym (109/L) | NA | 1.32 ± 0.74 | 1.64 ± 0.69 | 0.90 ± 0.58 | < 0.001 | NA |
| Cr admission (μmol/L) | NA | 143.73 ± 88.42 | 121.91 ± 54.94 | 172.10 ± 113.10 | < 0.001 | NA |
*Comparison between the stable KTRs and the infection KTRs.
#Comparison among the three groups.
HCs, healthy controls; KTRs, kidney transplant recipients; SD, standard deviation; DCD, donation after citizens’ death; WBC, white blood cell counts; Neu, neutrophils count; Lym, lymphocyte counts; Cr, serum creatinine; NA, not available.